Caroline has questioned why her mother was not diagnosed with lung cancer before her death, despite her declining health and having more than ten chest X-Rays between July 2020 and August 2023. One ...

The immunotherapy OST-HER2 combined with palliative radiation has shown positive data in preventing or delaying amputation ...

Enriqueta Felip, MD, PhD, discusses the design of the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab in metastatic NSCLC.

CNIO researchers found that in mice on high-fat diets, cancer cells in the bloodstream use platelets as a protective shield, ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

Investigators conducted a 4T1 breast cancer mouse model study to assess whether a combination of Shenhuang plaster, an herbal formula, plus paclitaxel could enhance the anti-tumor effects of ...

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any ...